Use of complement factor d inhibitor for treatment of geographic atrophy secondary to age-related macular degeneration
AssigneeAlexion Pharmaceuticals, Inc.
InventorsAleksandar Skuban, Mingjun Huang, David Boyer, Jose Rivera, Ya-Ping Ko, Xiang Gao
Life of this patent
Estimating the term…
Abstract
Disclosed herein are methods for treating geographic atrophy secondary to age-related macular degeneration (AMD) and intermediate AMD in a subject. The methods include administering to the subject a therapeutically effective amount of a small molecule complement factor D inhibitor.
Claims110
A method of treatment, wherein the method comprises treating geographic atrophy (GA) secondary to age-related macular degeneration (AMD) in at least one eye in a subject, said treating comprising administering to the subject an effective amount of Compound 1:
- or a pharmaceutically acceptable salt thereof, wherein the treatment comprises slowing or reversing a progression of the GA, wherein the slowing the progression of the GA comprises a reduction in a mean rate of increase in a total GA lesion area from baseline in the at least one eye, and the reversing the progression of the GA comprises a mean decrease in the total GA lesion area from baseline in the at least one eye.
A method of treatment, the method comprising treating intermediate AMD (iAMD) in at least one eye in a subject, said treating comprising administering to the subject an effective amount of Compound 1:
- or a pharmaceutically acceptable salt thereof, wherein the treatment comprises reducing the risk of the iAMD converting into late AMD as measured by SD-OCT.
Dependencies are inferred from the claim text.